concerns cancer development exposure environmental sources densely ionizing high linear energy transfer let radiation radon current public health issue study tumors attributable high let irradiation greatly augment insights biological mechanisms carcinogenesis chronic internal exposure thorium dioxide deposits following intravascular administration radiographic contrast agent thorotrast known markedly increase risk cancer development especially hepatic angiosarcomas cholangiocarcinomas mechanism hypothesized cellular damage dna major target wrought high let specific genes actual sequence events involved process transforming normal cell malignant largely unknown shed light molecular mechanisms cancer development lifetime exposure analyzed commonly affected tumor suppressor gene humans p53 NUMBER thorotrast recipients developed cancer hepatic bile duct blood vessel origin NUMBER cases NUMBER harbor p53 point mutations accompanying tissues patients p53 mutations albeit lower frequency distribution pattern point mutations significantly different tumor tissues mutations malignant tissues located highly conserved domains p53 gene results support idea p53 mutations important genesis tumors point mutations secondary outcome genomic instability induced irradiation additionally cells harboring p53 mutations gain survival advantage situ mutations domains responsible formation structural elements critical binding dna necessary cell reach malignancy alpha particles low dose rate alpha radiation alpha particles alpha radiation non tumor non tumor thorotrast induced non tumor